Trial lock

This content is not available with your current subscription.

Your current Info-Tech Research Group subscription does not include access to this content. Contact your account representative to learn more about gaining access to Healthcare.

Contact Your Representative or Call: 1-888-670-8889 (US) or 1-844-618-3192 (CAN)

Date published:


Watson for Oncology is IBM’s supercomputer solution, which claims to help “…doctors out-think cancer…,” may be more marketing than medicine. Despite being released to market in 2014, recent research reveals an IBM product that is not living up to the marketing hype, lacks substantive peer-reviewed scientific evaluations, and carries a staggeringly high total cost of ownership. IT leaders may be served best by allowing the competition to fund this product’s evolving technology.
  • Scott Bickley